The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Exosomal miR‐24‐3p impedes T‐cell function by targeting FGF11 and serves as a potential prognostic biomarker for nasopharyngeal carcinoma
Abstract
Recent studies have shown that extracellular microRNAs are not only potential biomarkers but are also involved in cell interactions to regulate the intercommunication between cancer cells and their microenvironments in various types of malignancies. In this study, we isolated exosomes from nasopharyngeal carcinoma (NPC) cell lines and patient sera (T‐EXOs), or control NP69 cells and healthy donor sera (HD‐EXOs). We found that miR‐24‐3p was markedly enriched in T‐EXOs as compared with HD‐EXOs; the serum exosomal miR‐24‐3p level was correlated with worse disease‐free survival of patients (p < 0.05). Knockdown of exosomal miR‐24‐3p (miR‐24‐3p‐sponge‐T‐EXOs) by a sponge RNA targeting miR‐24‐3p restored the T‐EXO‐mediated (control‐sponge‐T‐EXO) inhibition of T‐cell proliferation and Th1 and Th17 differentiation, and the induction of regulatory T cells (Tregs). Mechanistic analyses revealed that administration of exosomal miR‐24‐3p increased P‐ERK, P‐STAT1 and P‐STAT3 expression while decreasing P‐STAT5 expression during T‐cell proliferation and differentiation. Moreover, by in vivo and in vitro assessments, we found FGF11 to be a direct target of miR‐24‐3p. However, both miR‐24‐3p‐sponge‐T‐EXOs and T‐EXOs (control‐sponge‐T‐EXOs) impeded proliferation and Th1 and Th17 differentiation, but induced Treg differentiation, of lenti‐shFGF11‐transfected T cells. The levels of phosphorylated ERK and STAT proteins were different in lenti‐ScshRNA‐transfected T cells and lenti‐shFGF11‐transfected T cells following administration of miR‐24‐3p‐sponge‐T‐EXO. Interestingly, tumour FGF11 expression was positively correlated with the number of CD4+ and CD8+ T cells in vivo, and predicted favourable patient DFS (p < 0.05). Additionally, hypoxia increased cellular and exosomal miR‐24‐3p levels and enhanced the inhibitory effect of T‐EXO on T‐cell proliferation and differentiation. Collectively, our findings suggest that exosomal miR‐24‐3p is involved in tumour pathogenesis by mediating T‐cell suppression via repression of FGF11, and may serve as a potential prognostic biomarker in NPC. Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
Costa-Silva, B., Aiello, N. M., Ocean, A. J., Singh, S., Zhang, H., Thakur, B. K., Becker, A., Hoshino, A., Mark, M. T., Molina, H., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3169 · Cited by 2,692
Self-citationRegulation of immune responses by extracellular vesicles
Robbins, P. D., & Morelli, A. E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3622 · Cited by 2,260
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
Peng, D., Kryczek, I., Nagarsheth, N., Zhao, L., Wei, S., Wang, W., Sun, Y., Zhao, E., Vatan, L., Szeliga, W., et al. (2015) · Nature · doi:10.1038/nature15520 · Cited by 1,201
Lujambio, A., & Lowe, S. W. (2012) · Nature · doi:10.1038/nature10888 · Cited by 1,084
Umezu, T., Tadokoro, H., Azuma, K., Yoshizawa, S., Ohyashiki, K., & Ohyashiki, J. H. (2014) · Blood · doi:10.1182/blood-2014-05-576116 · Cited by 600
Cited by
Advances in Hypoxia-Inducible Factor Biology
Choudhry, H., & Harris, A. L. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.10.005 · Cited by 868
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Labani-Motlagh, A., Ashja-Mahdavi, M., & Loskog, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00940 · Cited by 751
Xu, Z., Chen, Y., Ma, L., Chen, Y., Liu, J., Guo, Y., Yu, T., Zhang, L., Zhu, L., & Shu, Y. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.046 · Cited by 319
Role of hypoxia-induced exosomes in tumor biology
Shao, C., Yang, F., Miao, S., Liu, W., Wang, C., Shu, Y., & Shen, H. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0869-y · Cited by 317
Recent advances in exosome-based immunotherapy applied to cancer
Xie, J., Zheng, Z., Tuo, L., Deng, X., Tang, H., Peng, C., & Zou, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1296857 · Cited by 40
Huang, Q., Yang, J., Zheng, J., Hsueh, C., Guo, Y., & Zhou, L. (2018) · Oncology Reports · doi:10.3892/or.2018.6672 · Cited by 19
Metadata
- Authors
- Ye, S., Zhang, H., Cai, T., Liu, Y., Ni, J., He, J., Peng, J., Chen, Q., Mo, H., Jun‐Cui, Zhang, X., Zeng, Y., & Li, J.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2016-10-19
- Volume
- 240
- Issue
- 3
- Pages
- 329-340
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W2508792834
- Cited by
- 238
- References
- 6
- FWCI
- 9.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.